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Two forms of cytochrome bg , a soluble rythrocyte form and a membrane-bound liver form, were purified 
from pig and human, and structural differences between them were analyzed. Porcine and human 
erythrocyte cytochrome b5 consisted of 97 amino acid residues and contained the same catalytic domain 
structure (residues l-96) as that of the corresponding liver cytochrome b5, but had one amino acid 
replacement a the C-terminus (residue 97). These results uggest that erythrocyte cytochrome bs is not 
derived from the liver protein by proteolysis but a translational product from another distinct mRNA of 
cytochrome b5. 
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1. INTRODUCTION 
Two forms of mammalian cytochrome b5 have 
been reported, a membrane-bound form in liver 
microsomes [l] and a water-soluble form in ery- 
throcytes [2]. Although the two forms are indis- 
tinguishable in catalytic and spectral properties, 
they differ slightly in molecular mass and amino 
acid composition [2-51. To clarify the structural 
differences between these forms, we have isolated 
erythrocyte and liver cytochrome b5 from pig and 
human, and characterized the tryptic fragments of 
two forms by various chemical approaches. We 
report here a structural comparison of tryptic pep- 
tides derived from two forms of cytochrome b5 and 
the differences in the C-terminal amino acid 
sequences. 
2. MATERIALS AND METHODS 
Cytochrome b5 from porcine and human ery- 
throcytes was prepared as in [2]. The apocyto- 
chrome bs was obtained by reverse-phase HPLC 
with a Nucleosil 5C8 column (10 x 250 mm) by a 
linear gradient of acetonitrile concentration from 0 
to 50% in 0.1% trifluoroacetic acid. Detergent- 
solubilized cytochrome b5 from porcine and human 
liver microsomes was purified as in [6]. The 
preparation of the liver apocytochrome b5 was 
obtained by reverse-phase HPLC under the same 
conditions as described above, except that 70% 
acetonitrile solution was used instead of 50%. 
Both erythrocyte and liver apocytochrome bs were 
digested with TPCK-trypsin (Washington) for 16 h 
at 37°C in 1% ammonium bicarbonate (pH 8.0). 
The tryptic digests were separated by reverse-phase 
HPLC with a Nucleosil5C8 column (10 x 250 mm) 
or an Ultrasphere ODS column (4.6 x 250 mm). 
The purified tryptic peptides were hydrolyzed at 
110°C for 20 or 24 h with 5.7N HCl containing 
0.1% thioglycollic acid. The amino acid sequences 
of the C-terminal peptides were determined by the 
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manual Edman method. PTH amino acid deriva- 
tives were identified by HPLC. 
3. RESULTS AND DISCUSSION 
The total amino acid composition of cytochrome 
bs was determined by using the hydrolysates of 
apocytochrome b5 and its tryptic fragments (table 
1). Cytochrome b5 isolated from porcine and human 
erythrocytes consisted of 97 amino acid residues. 
This size is intermediate between those of the de- 
tergent-solubilized (unmodified) liver cytochrome 
b5 (133 residues) and its trypsin-solubilized protein 
(about 90 residues) from which the hydrophobic 
membranous egment was removed. From porcine 
liver, unmodified cytochrome b5 was obtained con- 
sisting of 133 residues. However, from human liver 
a cytochrome b5 was purified that was comprised 
of 99 residues. Native cytochrome b5 from human 
liver which contains the membranous egment was 
Table 1 
not detected in our preparations. It appears that 
proteolysis of the native cytochrome b5 occurs 
during the purification steps. A similar degradation 
of rat liver cytochrome b5 was reported in [7]. The 
N-terminus of porcine and human erythrocyte 
cytochrome b5 was blocked similarly to the corres- 
ponding liver proteins and we failed to detect any 
PTH amino acid derivatives from the purified 
erythrocyte apocytochrome b5. 
Tryptic peptides of erythrocyte and liver cyto- 
chrome b5 from pig and human were analyzed by 
HPLC. From porcine erythrocyte and liver pro- 
teins, two peptide maps each containing 12 peaks 
corresponding to the tryptic peptides were ob- 
tained (fig.la). Only two peptides, namely PE6 
and PL6, were observed to have different retention 
times (arrows in fig.la). Their amino acid compo- 
sitions also differed, contrasting with the remaining 
11 peptide pairs which were identical in terms of 
retention time and amino acid composition. 
Amino acid compositions of erythrocyte and liver cytochrome bs 
Porcine 
Erythrocyte 
Human Rabbit” Bovineb 
Liver 
Porcine Human 
ASX 10 10 10 9 13 10 
Thr 6 6 6 7 11 7 
Ser 8 5 7 9 13 5 
Glx 16 17 14 16 18 17 
Pro 3 6 4 3 4 5 
GlY 6 6 6 6 6 6 
Ala 6 5 5 5 8 5 
Val 4 4 4 4 8 4 
Met 0 1 1 0 1 1 
Ile 6 4 4 5 9 5 
Leu 8 8 9 8 11 9 
Tyr 3 . 3 3 4 4 3 
Phe 3 3 3 3 4 3 
His 6 7 7 5 7 7 
Lys 8 8 10 9 8 8 
Trp 1 1 1 1 4 1 
Arg 3 3 3 3 3 3 
Total 97 97 97 97 133 99 
a 1101 
b [5] and unpublished 
Numbers of residues per mol are deduced from the averages obtained after hydrolysis of apocytochrome b5 with 3 M 
mercaptoethanesulfonic acid (Pierce) for 24, 48, 72 h and by the sum of the residues from tryptic peptides 
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Fig.1. (a) Reverse-phase HPLC of tryptic digests of 
porcine erythrocyte (-) and liver (- - -) cytochrome 
b5. Porcine erythrocyte (7 mg) and liver (4 mg) apocyto- 
chrome b5 were digested with TPCK-trypsin. The tryptic 
peptides were submitted to reverse-phase HPLC with a 
Nucleosil 5C8 column and eluted with a gradient of 
acetonitrile concentration (a) in 0.1% trifluoroacetic 
acid at a flow rate of 2.0 ml/min. A portion (1070) of the 
column effluent was diverted to the fluorescamine 
monitoring system [12]. (b) Reverse-phase HPLC of 
tryptic digests of human erythrocyte (-) and liver 
(- - -) cytochrome b5. Human erythrocyte (1 mg) and 
liver (2 mg) apocytochrome b5 were digested with TPCK- 
trypsin and the digest separated by reverse-phase HPLC 
with an Ultrasphere ODS column. The column was eluted 
as described above except that a flow rate of 1 ml/min 
and 4% for monitoring were used. In both (a) and (b), 
the tryptic peptides from liver cytochrome b5 yielded 
identical retention times with those of the corresponding 
erythrocyte proteins, except that PL6 (pig) and HL4 
(human) were present while PE6 and HE4 were missing 
in liver samples. The newly observed peptides were 
added to the erythrocyte maps (- - -). 
In the case of human samples, 10 tryptic 
peptide pairs were obtained (fig.lb). Again, one 
pair, HE4 and HL4, had different retention 
times and different amino acid compositions. 
The remaining 9 pairs were identical. Amino acid 
compositions of the tryptic peptides of porcine 
and human erythrocyte cytochrome by were com- 
pared with their known liver cytochrome b5 se- 
quences [8,9]. The peptide orders constructing 
the whole sequences of, respectively, porcine and 
human erythrocyte cytochrome bs were deduced 
as PES-PE3-PElO-PE2-PEl l-PE7-PE9-PE8-PE4- 
PE12-PE 1 -PE6 (PL6) and HE3-HE7-HE2-HE9- 
HE5HE%HE6-HEl-HElO-HE4 (HL4). In the case 
of porcine cytochrome bs, peptide PL6 was com- 
posed of 43 residues with a high proportion of 
hydrophobic amino acids and identified as the 
membrane anchoring segment (residues 91-133). 
In contrast, PE6 was found to be a short heptapep- 
tide. The amino acid sequence of PE6 was deter- 
mined by the manual Edman method and is shown 
in fig.2. As PE6 lacks a lysine or arginine residue 
at the C-terminus, it was identified as the C-termi- 
nal segment of porcine erythrocyte cytochrome bs . 
Serine was found at the C-terminus (residue 97) of 
PE6, while the corresponding residue 97 in the 
liver proteins is threonine [8]. The presence of 
threonine was confirmed by determining the par- 
tial sequence of PL6. 
In the case of human cytochrome bs, HE4 was a 
heptapeptide while HL4 was a nonapeptide. Their 
sequences were determined and are shown in fig.2 
together with those of erythrocyte and liver cyto- 
chrome bs from rabbit [lo] and bovine [5,1 I] origin. 
These results indicate that human erythrocyte 
cytochrome bs has one amino acid replacement 
(Thr + Pro) at the C-terminus (residue 97) com- 
pared to that of the liver protein. The results from 
the rabbit erythrocyte and liver proteins reported 
in [lo] are similar to our findings on the porcine 
and human proteins in that only one amino acid 
difference was found at the C-terminus (residue 97). 
The amino acid sequence of peptide HL4 in human 
liver cytochrome b5 was different from the partial 
sequence (Ile-Thr-Lys,Pro,Ser,Glu,Ser) of human 
liver cytochrome bs reported in [9]. We could not 
detect any tryptic peptides similar to the reported 
sequence. 
In the case of the bovine protein, erythrocyte 
cytochrome 65 has been reported to be identical to 
the fragment (residues l-97) of the liver cyto- 
chrome b5 (fig.2) by authors in [5]. They therefore 
concluded that the bovine erythrocyte cytochrome 
b5 is generated from the corresponding liver micro- 
somal protein by proteolytic digestion during 
maturation of erythrocytes. However, the findings 
of erythrocyte specific cytochrome b5 from por- 
cine, human and rabbit sources suggest strongly 
that bovine erythrocyte cytochrome b5 is not de- 
rived from the liver protein, although it contains 
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Porcine (E) 
(L) 
Human (E) 
(L) 
Rabbit (E) 
(L) 
Bovine (E) 
(L) 
90 97 
----Arg-Ser-Lys-Ile-Ala-Lys-Pro-Ser-Glu-(Ser)-COOH 
+PE6*-! 133 
----Arg-Ser-Lys-Ile-Ale-Lys-Pro-Ser-tilu-Thr-Leu-Ile------Asn-C~OH 
)-PL6 i 
----Lys-Pro-Arg-Leu-Asn-Lys-Pro-Pro-Glu~COOti 
*=-I 
----Lys-Pro-Arg-Leu-Asn-Lys-Pro-Pro-Glu-Thr-Leu-Ile-CO~H 
C-------HL4,pI 
----Arg-Ser-Lys-Leu-Ser-Lys-Pro-Met-Glu_1ProtCOOH 
----Arg-Ser-Lys-Leu-Ser-Lys-Pro-Met-Glu-Thr-Leu-Ile------ 
----Arg-Ser-Lys-Ile-Ser-Lys-Pro-Ser-Glu-Ser-COOH 
----Arg-Ser-Lys-Ile-Ser-Lys-Pro-Ser-Glu-Ser-Ile-Ile------ 
ref. 
(a) 
(b) 
(a) 
(a) 
(C) 
(d) 
(e) 
(f) 
Fig.2. C-terminal sequences of erythrocyte (E) and liver (L) cytochrome bs. The residues in erythrocyte cytochrome bg 
which differ from the corresponding residues in the liver protein are boxed. a, Here; b, [8]; c, [lo]; d, [13]; e, [5] and 
unpublished; f, [ 141. 
no amino acid replacement. These results suggest 
that mammalian erythrocyte cytochrome b5 con- 
sists of 97 amino acid residues containing the com- 
mon catalytic domain structure and lacks the 
C-terminal membranous egment of the liver pro- 
tein. Its characteristic structure allows the protein 
to be soluble in red cells. Furthermore, these 
results suggest that the two forms of cytochrome b5 
are coded for by two different mRNAs. These con- 
clusions raise the interesting question of how the 
two forms of cytochrome b5 are generated in 
erythrocytes and liver. It is possible that the two 
distinct mRNAs for the two forms are synthesized 
from two closely related but different genes. Alter- 
natively, a mechanism generating the two different 
mRNAs from a single gene may also be possible. 
Irrespective of the biosynthetic mechanisms, one 
C-terminal type which characterizes cytochrome bs 
in a specific form, seems to be selected in a tissue- 
specific manner. The finding of two distinct forms 
of cytochrome b5 in erythrocyte and liver provides 
a good model for understanding the gene expres- 
sion mechanism in different cell types. Further 
studies are in progress to clarify the biosynthetic 
mechanism. 
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